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Humoral immune capacity in recurrent E. coli upper urinary
tract infection. In patients with recurrent upper urinary tract in-
fection, humoral immune capacity was assessed from the anti-
body response to primary immunization with monomeric
flagellin from Salmonella adelaide. Antibody producing capacity
was similar to that of other hospital patients, but impaired
compared with healthy subjects. No correlation was found be-
tween antibody response to flagellin and antibody response to
the 0 antigen of the infecting organism, E. coil, but "natural"
antibody to flagellin was higher in patients with high titers of
antibody to 0 antigen. Deficient antibody producing capacity
could not be implicated as a determinant of recurrent upper
urinary tract infection.
Competence immunitaire humorale au cours des infections ré-
currentes de l'arbre urinaire supérieur a escherichia coli. La corn-
pétence immunitaire humorale a été èvaluée chez des patients
souffrant d'infections récurrentes de l'arbre urinaire supérieur
par leur capacité a former des anticorps en réponse a une im-
munisation primaire avec l'antigéne flagellaire monophasique du
salmonella adelaide. Leur capacité de formation d'anticorps
était comparable a celle d'autres patients hospitalisés, mais
amoindrie comparativement a celle de sujets bien portants.
Aucune correlation ne fut retrouvée entre leur capacité de forma-
tion d'anticorps en réponse a l'antigéne flagellaire d'une part et
a l'antigéne 0 de l'agent infectieux, E coli, d'autre part. Par
contre, l'anticorps flagellaire <<naturel>> était plus élevé chez les
patients ayant de hauts niveaux d'anticorps a l'antigène 0. En
conclusion, une incompetence dans Ia formation d'anticorps ne
peut être impliquée comme facteur determinant au cours des
infections récurrentes de l'arbre urinaire supCrieur.
Specific humoral antibody has been shown to be protec-
tive in experimental pyelonephritis [1—21, more particularly
in infections with certain organisms, e.g. E. co/i, than in
others, e.g. Kiebsiella and Proteus. The protective effect of
specific humoral antibody in human urinary tract infection
is less definite [3—5]. Thus, Martin, Bronstein and Dray [3]
reported on the high frequency of pyelonephritis in patients
with agammaglobulinemia, and Winberg et al [4] con-
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sidered that the absence of a specific hemagglutinin re-
sponse could predispose to acute pyelonephritis in infants
less than two months old, in whom immune responsiveness
may be relatively weak. Also Winberg Ct al [4] observed
that cystitis, in which there is usually no demonstrable
specific antibody response by hemagglutination, showed
much less tendency to terminate spontaneously than did
uncomplicated acute pyelonephritis in which there is usually
a rapid and pronounced specific antibody response. On the
other hand, pyelonephritis in man can become recurrent or
chronic despite the low pathogenicity of the bacteria usually
involved, indicative of some defect in host defense
mechanisms.
It has been found from this center [6] that urinary infec-
tion in man could be reliably localized to the upper or
lower tract by a single test involving only bladder catheteri-
zation. High levels of hemagglutinating antibodies to the
O antigen in E. coli infection correlated with upper rather
than lower tract infection [4, 7], but in certain cases of
proven upper tract infection antibodies were present in
only low titer [8—9]. Possible explanations for these findings
include non-invasion of renal substance (pyelitis), poor im-
munogenicity on the part of the infecting organism and an
impaired immune response of the host. The latter could
explain the poor antibody response to renal infection in
such patients [8, 10], which in turn could account for
persistent or recurrent infection. Accordingly, this pos-
sibility was tested by a standard clinical test of antibody
producing capacity, using immunization with flagellin from
Salmonella adelaide (S. adelaide) [11].
Methods
The patients comprised 37 women and two men with a
history of two or more episodes of symptomatic urinary
tract infection with bacterial counts in the urine of more
than 100,000 bacteria per ml. The patients ranged in age
from 18 to 68 years with a mean of 40 years. In each of the
288 Whit worth et al
a Geometric means and range (±2 SEM).
b No range is given for values of five or less.
patients, on at least one occasion, the site of infection was
identified as upper tract, as opposed to bladder, by the
method of Fairley et al [6] and Fairley [9]. Also, a study
by Whitworth, Fairley, Johnston and O'Keefe (unpub-
lished) using a renal pelvic washout technique at cystoscopy
has established that upper tract infection, as diagnosed by
the bladder washout technique, is due to renal parenchymal
infection rather than pyelitis. It was considered that no
useful additional information would be obtained from
indirect and less discriminative procedures such as tests of
urine concentration and intravenous pyelograms, recog-
nising that pyelitis alone may impair renal concentrating
ability by producing minimal edema at the papillary tip [13].
Antibodies to the 0 antigen of the infecting organism,
E. coli, at the time of localization were measured by the
hemagglutination technique of Neter et al [12]. For the
purpose of subsequent analysis, hemagglutinating antibody
titers of > 1280 were regarded as "high" (14 patients),
and titers <320 in all serial specimens in the succeeding
three months after localization as "low" (11 patients). All
patients studied were outpatients; in none was the level of
serum urea as determined by an autoanalyzer method
greater than 60 mg/100 ml, none had received immuno-
suppressive drugs and none had active infection as judged
by a midstream urine specimen at the time of immunization
with flagellin.
The control groups were derived from 1) patients who
were in the hospital or attending an out-patient clinic,
"hospital controls", and who were suffering from diseases
believed not to affect the function of the immunological
system and 2) healthy subjects, "healthy controls". Patients
with recurrent upper urinary tract infection were compared
with a sex matched group of "hospital controls" of mean
age 46 years and with a similarly matched group of "healthy
controls" of mean age 53 years.
Monomeric flagellin from S. adelaide was prepared and
5 jig used for immunization [11]. Samples of blood were
obtained at specified time points and antibody was titrated
by tanned cell hemagglutination using whole serum for
estimation of total antibody and serum treated for one hr
with 2-mercaptoethanol (ME) for estimation of IgG anti-
body [11, 14]. Geometric means of titers of antibody were
calculated for patients in the various groups, titers below
five being given the value one. Differences between the
mean for the various groups were compared by the Rank
test.
Results
Natural antibody toflagellin is of 1gM class [14] and was
detected in pre-immunization sera from 90 to 97% of all
subjects tested. The mean titers for patients and controls
(Table 1) did not differ significantly but the mean titer of
156 for patients with a high titer of 0 antibody was signifi-
cantly greater (P <0.05) than that of 27 for the group with
a low titer of 0 antibody (Table 2).
Immune antibody to flagellin. The mean peak titer at two
weeks of total antibody to flagellin for the patients (1430)
was significantly less (P-cO.Ol) than that for healthy con-
trols (4397), but was not significantly different from that
for hospital controls (1646). The mean titer of total anti-
body at ten weeks for the patients (645) was not significantly
different from either that of healthy controls (981) or of
hospital controls (657). However, the mean peak titer of
IgG antibody of the patients with renal infection (232) was
Table 2. Titers of total and TgG antibody before, and two and
ten weeks after injection of flagellin in "high" and "low"
producers of antibody to 0 antigen of F. colic'
Time Anti-
body
Antibody to 0 antigen E. co/i
.High Low"_—
Mean Range Mean Range
Before Total 156 77.8—369 27 7.54—96.7
immu- IgG 5b - lb
nization
Two weeks Total 1418 710—2829 1859 690—5003
after IgG 405 118—1 386 206 60.5—701
immu-
nization
Ten weeks Total 642 320—i 286 594 277—1270
after TgG 58 18.2—184 44 13.2—146
immu-
nization
Table 1. Titers of total and IgG antibody before and two and ten weeks after immunization with flagellin in patients with renal tract
infection (RT I) and controlsa
Time Antibody
Groups
RT I Healthy controls Hospital controls
Mean Range Mean Range Mean Range
Before
immunization
Two weeks after
immunization
Ten weeks after
immunization
Total
IgG
Total
IgG
Total
TgG
70
3b
1430
232
645
43
39.4—t12
—
976—2095
126—428
452—919
23.3—79.3
45
lb
4397
80
981
11
24.7—81.9
2224—8694
34.1—187
583—1651
5.0—24.2
48
1b
1646
50
657
2t
28.6—80.4
759—3568
19.1—130
285—1512
6.4—68.9
o Geometric means and range (± 2 SEM).
a No range is given for values of 5 or less.
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Fig. 3. Peak titers of antibody to 0 antigen of E. co/i plotted
against peak titers of immune antibody to f/age/un. There was no
correlation.
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Fig. 1. Geometric mean titers over ten weeks of total antibody(—) and IgG (ME-resistant) antibody ( ) to flagellin in
patients with upper urinary tract (renal) infection and matched
healthy and hospital controls. Vertical bars indicate one SEM.
For patients with upper urinary tract (renal) infection, mean
peak titers of total antibody were less than for healthy controls, 0 antibody to E. coli, the infecting organism (Fig. 3). Thuswhereas mean titers of IgG antibody were greater. in six of 14 patients who produced high titers (>1280) of
0 antibody the peak titer of antibody to flagellin was less
greater than that of healthy subjects (80) and significantly than the geometric mean for all patients with recurrent
greater (P <0.02) than that of hospital controls (50); in upper urinary tract infection, whereas in eight of 11 patients
with low titers of antibody, the peak titer in response tofact, the higher production of IgG antibody to flagellin in
patients versus healthy and hospital controls held through- flagellin exceeded the geometric mean for the entire group.
out the response, being marked at one week and persisting
Discussion
at six weeks and ten weeks (Fig. 1).
The humoral response to flagellin from S. adelaide, as
"High" and "low" 0 hemagglutinating antibody groups.
The patients were grouped according to their titer of described by Rowley and Mackay [111, has been used to
demonstrate impaired antibody producing capacity inhemagglutinating 0 antibody to E. co/i, > 1280 and <320.
various clinical situations including therapeutic immuno-The response of total antibody to flagellin for the two
groups was similar (Fig. 2), but the IgG antibody response suppression [15] and cancer [16]. This present study adds
to flagellin of those with a high 0 antibody to E. co/i to previous evidence [11] that healthy subjects have a
tended to be higher than the response of those with a low significantly greater capacity for antibody production than
o antibody. For individual patients there was no correla- ill persons even though the illness is of a relatively minor
tion between titer of total antibody to flagellin and titer of nature.
The purpose of our study was to assess firstly whether
one determinant of recurrent urinary infection was an
overall deficiency in humoral immune responsiveness and
High 0 Titer secondly, whether those patients with upper urinary tract
infection who show a poor antibody response to the 0
antigen of the infecting organism, E. co/i, might differ in
antibody producing capacity from those with a pronounced
antibody response. The study failed to demonstrate any
overall impairment of antibody producing capacity in
patients with recurrent upper tract infection other than
that attributable to illness itself, nor any difference in total
antibody producing capacity between patients with upper
tract infection with high or low titers of antibody to the
O antigen. Moreover, there was no demonstrable correla-
10
tion between peak titer to flagellin, an H antigen, and peak
titer of antibody against the 0 antigen of the infecting
organism.
Our investigation was not designed to assess all causal
aspects of recurrent urinary infection, particularly the local
3
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Fig. 2. Geometric mean titers over ten weeks of total antibody(—) and IgG (ME-resistant) antibody ( ) to flagellin
were similar in patients grouped according to titer of antibody to
0 antigen of E. coli.
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factors which may be of importance in susceptibility to
infection as judged from studies by Beeson and Rowley [17],
Lehmann et al [18] and Hanson et al [19]. Nor did we at-
tempt to assess bacterial properties which might determine
invasion of the upper urinary tract. Glynn, Brumfitt and
Howard [20] showed that a high content of K antigen in
E. co/i correlated with renal involvement. Finally, the
design of the present study did not include assessment of
the immunogenicity of the numerous E. co/i serotypes, if
indeed this could be done in an immunologically meaning-
ful way in relation to human infection.
The titer of "natural" antibody to flagellin was shown
previously to be unrelated to the magnitude of the immune
antibody response [II], a finding confirmed in this study.
However "natural" antibody to flagellin was higher in
patients with high titers of antibody to the 0 antigen of
E. co/i than in those with low titers of antibody to
O antigen. Other findings of interest were the consistently
higher titer of immune IgG antibody to flagellin in patients
with upper tract infection than in both healthy and hospital
controls and the tendency for higher titers of lgG antibody
to flagellin in those patients with a high titer of antibody to
O antigen. These observations may be explained by con-
tinued antigenic stimulation in patients with urinary infec-
tion, particularly in those with a high response to the
O antigen; this assumes that antigens of E. coil would
facilitate, through cross reactivity, responses to subse-
quently administered flagellin from S. adelaide. Kunin [21]
showed that urinary tract infection acquired after two years
of age could occur in the presence of pre-existing serum
antibody which was presumably acquired by immunization
from bacteria in the gut; this observation and our present
findings indicate that neither high levels of "natural" anti-
body nor an intact humoral immune response are protec-
tive against recurrent infection.
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